Osteal Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Osteal Therapeutics's estimated annual revenue is currently $4.3M per year.
- Osteal Therapeutics's estimated revenue per employee is $105,402
- Osteal Therapeutics's total funding is $117M.
Employee Data
- Osteal Therapeutics has 41 Employees.
- Osteal Therapeutics grew their employee count by 41% last year.
Osteal Therapeutics's People
Name | Title | Email/Phone |
---|---|---|
1 | President & CEO | Reveal Email/Phone |
2 | Chief Technology Officer | Reveal Email/Phone |
3 | Chief Operating Officer | Reveal Email/Phone |
4 | Co-Founder & CTO | Reveal Email/Phone |
5 | Chief Commercial Officer | Reveal Email/Phone |
6 | VP Clinical Affairs | Reveal Email/Phone |
7 | VP R&D | Reveal Email/Phone |
8 | VP Market Access | Reveal Email/Phone |
9 | VP Quality Assurance | Reveal Email/Phone |
10 | VP Marketing | Reveal Email/Phone |
Osteal Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $32.4M | 161 | 20% | N/A | N/A |
#2 | $16.3M | 81 | 7% | N/A | N/A |
#3 | $18.7M | 93 | 16% | N/A | N/A |
#4 | $62.5M | 0 | N/A | N/A | N/A |
#5 | $12.3M | 61 | 7% | N/A | N/A |
#6 | $3.2M | N/A | $22.2M | N/A | |
#7 | $184.1M | 916 | 38% | $50M | N/A |
#8 | $27.7M | 138 | 8% | N/A | N/A |
#9 | $112.4M | 559 | 8% | N/A | N/A |
#10 | $12.5M | 62 | 11% | N/A | N/A |
What Is Osteal Therapeutics?
Osteal Therapeutics is a privately-held, clinical-stage pharmaceutical company developing novel musculoskeletal therapeutics to treat orthopedic infections and their consequences.
keywords:N/A$117M
Total Funding
41
Number of Employees
$4.3M
Revenue (est)
41%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $8.9M | 41 | N/A | N/A |
#2 | $7.8M | 41 | 21% | N/A |
#3 | $3.9M | 41 | -2% | N/A |
#4 | $8.8M | 41 | 128% | N/A |
#5 | $10.3M | 41 | 11% | $35M |